Brief: Quoin Pharmaceuticals Announces International Expansion Of Ongoing Clinical Trials For Netherton Syndrome
27/06/2024 13:38
June 27 (Reuters) - Quoin Pharmaceuticals Ltd 2EBy.BE :
* QUOIN PHARMACEUTICALS ANNOUNCES INTERNATIONAL EXPANSION OF
ONGOING CLINICAL TRIALS FOR NETHERTON SYNDROME
* QUOIN PHARMACEUTICALS LTD- CLINICAL SITE TO BE OPENED IN
SAUDI
ARABIA
* QUOIN PHARMACEUTICALS ANNOUNCES INTERNATIONAL EXPANSION OF
ONGOING CLINICAL TRIALS FOR NETHERTON SYNDROME
Source text for Eikon: ID:nGNX8bHWr4
Further company coverage: 2EBy.BE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quoin Pharmaceuticals
See all newsQuoin Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM